EWSR1-SMAD3 positive fibroblastic tumor: a clinicopathological analysis.
10.3760/cma.j.cn112151-20221002-00828
- Author:
Hai Yan SU
1
;
Lu ZHAO
2
;
Gang JI
2
;
Qian Lan YAO
2
;
Qian Ming BAI
2
;
Xiao Yan ZHOU
2
;
Jian WANG
2
Author Information
1. Department of Pathology, Zhangzhou Municipal Hospital of Fujian Medical University, Zhangzhou 363000, China.
2. Department of Pathology, Fudan University, Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Child;
Female;
Humans;
Male;
Biomarkers, Tumor/analysis*;
China;
In Situ Hybridization, Fluorescence;
Neoplasms, Fibrous Tissue/pathology*;
RNA-Binding Protein EWS/genetics*;
Smad3 Protein/genetics*;
Soft Tissue Neoplasms/surgery*
- From:
Chinese Journal of Pathology
2023;52(1):19-24
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinicopathological features, immunophenotypes and molecular genetics of EWSR1-SMAD3 positive fibroblastic tumor (ESFT) with an emphasis on differential diagnosis. Methods: The clinicopathological data, immunohistochemical profiles and molecular profiles of 3 ESFT cases diagnosed at the Department of Pathology, Fudan University Shanghai Cancer Center from 2018 to 2021were analyzed. The related literature was also reviewed. Results: There were two males and one female. The patients were 24, 12 and 36 years old, respectively. All three tumors occurred in the subcutis of the foot with the disease duration of 6 months to 2 years. The tumors were presented with a slowly growing mass or nodule, accompanied with pain in 1 patient. The tumors ranged in size from 0.1 to 1.6 cm (mean, 1.0 cm). Microscopically, the tumors were located in the subcutaneous tissue with a nodular or plexiform growth pattern. They were composed of cellular fascicles of bland spindle cells with elongated nuclei and fine chromatin. One of the tumors infiltrated into adjacent adipose tissue. There was no nuclear atypia or mitotic activities. All three tumors showed prominent stromal hyalinization with zonal pattern present in one case. Focal punctate calcification was noted in two cases. The immunohistochemical studies showed that tumor cells were diffusely positive for ERG and negative for CD31 and CD34, with Ki-67 index less than 2%. Fluorescence in situ hybridization on the two tested cases identified EWSR1 gene rearrangement. The next generation sequencing analysis demonstrated EWSR1-SMAD3 fusion in all three cases. During the follow up, one patient developed local recurrence 24 months after the surgery. Conclusions: ESFT is a benign fibroblastic neoplasm and has a predilection for the foot, characterized by ERG immunoreactivity and EWSR1-SMAD3 fusion. Local recurrence might occur when incompletely excised. Familiarity with its clinicopathological features is helpful in distinguishing it from other spindle cell neoplasms that tend to occur at acral sites.
